With ri:val, you can generate robust valuation results in a standalone
software package. It's powerful, battle-tested, and easy to use.
Flexible program design gives users the
full power of ri:val or the advantage of targeted modules.
ri:val offers tools to deliver accurate valuations for M & A, fundraising,
business development and more.
Visit our resource center to find out about valuation methodology, FAQs about ri:val and more.
ri:val is the leading valuation solution for business developers, investors,
CFOs, and CEOs in pharma and biotech. You can generate valuation results far
beyond any error-prone spreadsheet calculation and quickly explore multiple
scenarios. ri:val provides access to up-to-date industry data on drug development.
Valuations of license contracts, drug development projects, pipelines, and
biotech or pharma firms are easily done in a comprehensive, user-friendly framework.
Valuation is no longer a challenge — it is your tool for success.
February 11 >The new ri:val v4.1 now allows companies to plan their resource allocation taking account of different scenarios.